Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASMQ plus primaquine for uncomplicated malaria in Laos
ACTRN12618001349235Phase 4Not yet recruiting
- Sponsor
- Ministry of Health
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of artesunate, mefloquine and primaquine in malaria and Malaria (2 cohorts), sponsored by Ministry of Health. Primary endpoint: Treatment success confirmed by microscopy and PCR. Planned start Aug 2018; status: not yet recruiting.
02
Drugs
artesunatemefloquineprimaquine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on ACTRN12618001349235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001349235.